Biotech Stocks

biotech stocks Heres What to Expect From Australian Biotechs
Source: ©iStock.com/AlexRaths
Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

Recent Articles

Here’s What to Expect From Australian Biotechs

Australian science is strong and a leader in the biotech space. Here's why investors should look to Australia for biotech stocks to buy. More 

Biogen (BIIB) Flexes Its Biotech Biceps

Biogen rallied nicely Wednesday, attacking technical resistance once more. This persistence should result in a major breakout of BIIB stock. More 

A Seismic Shift To Boost Biotech Stocks

Given the low capitalization prices from recent changes in drug companies, investors would be smart to take positions in biotech stocks now. More 

Great Biotech Stocks for Retirement Investors

Yes, Biotech stocks DO belong in your retirement portfolio. Here are three ways to add them and reap the rewards. More 

5 Red-Hot Biotech Stocks

The bricks are coming off the market's shoulders, and these five hot biotech stocks are among the top beneficiaries. More 

Hide Out from Volatility in … Biotech?

On April 19, Zafgen sold six million shares, one million more than initially planned. More 

4 Biotech Stocks to Buy

If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy More 

3 Reasons Why Biogen Stock Is Still a Buy (BIIB)

Janet Yellen might think biotech valuations are stretched, but the Street thinks companies like Biogen (BIIB) are just worth the growth More 

3 Biotech Stocks That Belong in Your Portfolio

The recent pullback in biotech stocks is an opportunity for investors to appeal to both growth and value in this dynamic sector. More 

Dow Theory Buy Signal Confirmed

The industrials broke to a new closing high, putting the pressure on the bears. More